ACTIVITY IN THE THIRD QUARTER OF 2014
(Unaudited data)
Development of business in the third quarter (variation at current rate)
thousands of euros
1st Quarter
2nd Quarter
3rd Quarter
2013
2014
Var.
14/13
2013
2014
Var.
14/13
2013
2014
Var.
14/13
France
84,270
82,749
-1.8%
75,327
74,269
-1.4%
92,596
92,466
-0.1%
International :
73,751
57,460
-22.1%
42,436
47,138
+11.1%
76,890
79,646
+3.6%
Incl. Europe excluding France
54,334
39,967
-26.4%
29,047
33,570
+15.6%
61,256
62,758
+2.5%
Incl. North America
15,562
12,662
-18.6%
10,017
10,625
+6.1%
12,153
13,109
+7.9%
Incl. Other countries
3,855
4,831
+25.3%
3,372
2,943
-12.7%
3,481
3,779
+8.6%
Group Total
158,021
140,209
-11.3%
117,763
121,407
+3.1%
169,486
172,112
+1.5%
thousands of euros
1st Quarter
2nd Quarter
3rd Quarter
2013
2014
Var.
14/13
2013
2014
Var.
14/13
2013
2014
Var.
14/13
Non-proprietary Homeopathic Medicines
79,062
77,919
-1.4%
73,035
73,072
+0.1%
73,597
72,957
-0.9%
OTC Specialties
78,866
62,196
-21.1%
44,600
48,058
+7.8%
95,813
99,025
+ 3.4%
Other
93
94
+1.1%
128
277
+116.4%
76
130
+71.1%
Group Total
158,021
140,209
-11.3%
117,763
121,407
+3.1%
169,486
172,112
+1.5%
Cumulative activity as of the end of september 2014
thousands of euros
2013
2014
Variation at current exchange rates
Variation at constant exchange rates
France
252,193
249,484
- 1.1%
- 1.1%
International :
193,077
184,244
- 4.6%
- 1.2%
Incl. Europe excluding France
144,637
136,295
- 5.8%
- 2.4%
Incl. North America
37,732
36,396
- 3.5%
+ 0.4%
Incl. Other countries
10,708
11,553
+ 7.9%
+ 10.2%
Group Total
445,270
433,728
- 2.6%
- 1.1%
thousands of euros
2013
2014
Variation at current exchange rates
Variation at constant exchange rates
Non-proprietary Homeopathic Medicines
225,694
223,948
- 0.8%
- 0.5%
OTC Specialties
219,279
209,279
- 4.6%
- 1.8%
Other
297
501
+ 68.7%
+ 63.6%
Group Total
445,270
433,728
- 2.6%
- 1.1%
Highlights of the third quarter
Sales revenue in the third quarter 2014 grew by 1.5% compared to 2013 (3.3% at constant rates).
On September 30, 2014, the group cash balance amounted €134.7 million.
Outlook
Considering the uncertainty of seasonal illnesses in the last quarter, the group is still cautious regarding its 2014 outlook.
Our next update: January 22, 2015 at market close, publication of the sales revenue for the year 2014.
Financial information manager: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at : www.boiron.com
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-37682-BOI-231014-CA-T3-14-GB.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews